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Abstract 
Diabetes mellitus (DM) is a major and worsening global health problem, currently affecting over 
450 million people and reducing their quality of life. Type 2 diabetes mellitus (T2DM) accounts 
for more than 90% of DM and the global epidemic of obesity, which largely explains the 
dramatic increase in the incidence and prevalence of T2DM in the past 20 years. Obesity is a 
major risk factor for DM which is a major cause of morbidity and mortality in diabetic patients. 
The electro-mechanical function of the heart is frequently compromised in diabetic patients. The 
aim of this review is to discuss the pathophysiology of electro-mechanical dysfunction in the 
diabetic heart and in particular, the Zucker diabetic fatty (ZDF) rat heart, a well-studied model of 
T2DM and obesity. 
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1. Introduction 
DM is a major metabolic disorder which is characterized by high blood glucose levels over a 
prolonged period. DM is a major global health problem. According to statistics from the 
International Diabetes Federation in 2017 [1], 450 million people worldwide had DM. The 
number of diabetic patients is expected to reach 629 million by the year 2045. In 2017, there 
were an estimated 39 million people with diabetes in the Middle East and Northern Africa 
region. Diabetes is classified into different types. Type 1 diabetes mellitus (T1DM) is 
characterized by near total pancreatic β- cell destruction, usually leading to absolute insulin 
deficiency. T2DM is the most common form of the disease accounting for more than 90% of all 
DM. T2DM is characterized by target cell insulin resistance and a progressive decrease in the 
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number of functional insulin insulin-producing β- cells. A third type of DM which affects 
pregnant women, called Gestational gestational diabetes, is also characterized by insulin 
resistance and insulin deficiency. Other forms of diabetes include types related to genetic defects 
in insulin action, genetic defects of β- cell function, and others like endocrinopathies, drug or 
chemical-induced and diseases of exocrine pancreas [2]. If DM is diagnosed late or left 
untreated, it can lead to a number of long-term complications including diabetic cardiomyopathy 
(DCM) and a reduction in the quality of life for the patient. Generally, cardiovascular diseases 
(CVDs) are the major cause of morbidity and mortality in diabetic patients [3]. In young people 
with T1DM (8 - –43 43 years), around 5 out of 1,000 people die from CVDs on a yearly basis, 
whereas among middle-aged people with T2DM living in high- and middle middle-income 
countries, up to 27 out of 1,000 people die from CVDs each year; a third of them die from stroke, 
and a quarter die from coronary artery disease (CAD) [1]. Electro-mechanical dysfunction of the 
heart is a frequent occurrence in diabetic patients [4]. Atrial fibrillation (AF) and ventricular 
arrhythmias (VA) are the most common forms of arrhythmias found in diabetic patients. Left 
ventricular diastolic dysfunction, increased pulse pressure, and also prolonged QTc of the 
electrocardiogram are also frequently reported in the diabetic heart. This review discusses the 
prevalence of obesity and its relationship to DM, normal electro-mechanical activity of the heart, 
the development of DCM, the ZDF rat as a model of diabetes and obesity, and the mechanisms 
underlying electro-mechanical dysfunction in the ZDF rat heart. 
2. Obesity: Epidemiology epidemiology and pathophysiology  
Obesity is considered a major health problem globally and it is collectively related to metabolic 
syndrome. The World Health Organization (WHO) defines obesity as “an abnormal or excessive 
fat accumulation in adipose tissue, to the extent that health is impaired”. The currently accepted 
classification of obesity for epidemiological purposes defines overweight as a body mass index 
(BMI) greater than 25 25 kg/m
2
 and obesity starting from a BMI of 30 30 kg/m
2
 [5]. It is an 
exaggeration of normal adiposity and is a key player in the pathophysiology of DM, insulin 
resistance, dyslipidemia, hypertension, atherosclerosis, CAD, stroke, liver disease, sleep apnea, 
osteoarthritis, psychological illnesses, some musculoskeletal conditions, gynecological 
complications, and cancer, specifically breast and colon [6]. Due to the dramatic increase in 
prevalence over the last few decades, obesity has become a pressing concern for health care 
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officials worldwide. The WHO outlines the severity of the problem in the following global key 
estimates: in 2014, more than 1.9 billion adults aged 18 18 years and older were overweight. Of 
these, over 600 million adults were obese. Overall, about 13% of the world’s adult population 
(11% of men and 15% of women) were obese in 2014, while 39% of adults aged 18 18 years and 
over (38% of men and 40% of women) were overweight. The worldwide prevalence of obesity 
has more than tripled between 1975 and 2016, representing 30% of the world’s population. An 
estimated 41 million children under the age of 5 5 years were overweight or obese in the year 
2014 and this is a major global and Governmental governmental concern [5]. According to the 
Lancet Commission report, obesity was estimated to affect 2 billion people worldwide in 2015 
and the current costs are estimated annually at about 2 trillion US dollars from direct health care 
costs and lost economic productivity [7]. 
Obesity is a multi-factorial disorder resulting from a combination of lifestyle, environmental, and 
genetic factors. Reduction in physical activity, metabolic rate, and thermogenesis eventually 
decrease energy expenditure leading to increased energy storage and obesity. Some of the causes 
of obesity include availability of palatable addictive fast food, sedentary lifestyle, leptin 
resistance, aggressive marketing of food, engineered junk foods, certain medications as well as 
genetic factors. Figure 1 illustrates some of the factors that contribute to obesity and thus, leading 
to metabolic syndrome [8]. 
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Figure Fig. 1: Flow diagram showing the energy balance and etiology of obesity (Adapted 
adapted from [8]). 
Obesity is characterized by excess fat in the body which contributes to harmful metabolic 
consequences. Moreover, obesity represents a significant medical and socio-economic burden. 
According to a recent report, the global cost of treating obesity has risen to 2 trillion US dollars 
[7, 9]. 
Obesity is a consequence of an adverse increase in adipose tissue mass resulting from increased 
fat cell size (hypertrophy) or number (hyperplasia) [10, 11]. These two events, together, 
orchestrate a series of co-morbidities leading to the development of obesity. Targeting adipocyte 
biology and identifying potential factors that can regulate these processes may be of significant 
importance in the prevention and treatment of obesity. 
3. Relationship between obesity and type 2 diabetes mellitus 
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People who are obese are more likely to develop T2DM. The obesity-induced T2DM is normally 
referred to as the metabolic syndrome or insulin resistance or adult pre-diabetes leading to 
persistent high level of blood glucose. In this condition, the body synthesizes and releases 
enough insulin in the blood, but the cells in the body become resistant to the salutary action of 
insulin [12]. 
In recent years, scientists have developed a novel model of T2DM and obesity called the ZDF rat 
[13]. This model is obese in nature and it develops T2DM as well as inflammation. As such, it is 
an ideal model to understand how obesity-induced T2DM can lead to DCM. Before discussing 
the mechanisms that underlie electro-mechanical dysfunction in the ZDF rat heart, it is important 
to discuss the metabolic changes that are associated with T2DM. 
4. Type 2 diabetes mellitus and metabolic changes in the body 
In 2017, it was estimated that the number of adults (aged 20-–79 79 years) with DM was around 
450 million representing 87-–91% of all confirmed diabetes worldwide. In addition, 212.4 
million persons have unreported diabetes or are unaware of their disease [1]. Furthermore, 
around 1.5 billion people globally have pre-diabetes. Patients with T2DM differ from T1DM 
because they do not have near total destruction of pancreatic β- cells, but instead, suffer from 
insulin resistance which affects three major tissues of the body: the liver, muscle, and adipose 
tissues due to the hyperglycemia. In insulin resistance, there is minimal ketosis since insulin 
diminishes hepatic ketogenesis. The dyslipidemias are similar to those with T1DM and include 
increased plasma levels of very- low density lipoproteins (VLDL) and chylomicrons resulting in 
hypertriacylglycerolemia and lower high density lipoproteins (HDLs) may also be present [14]. 
Figure 2 shows the metabolic changes which occur in T2DM. 
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Figure Fig. 2: Diagram showing metabolic changes occurring in T2DM (Adapted adapted from 
[14]). 
5. Electrical activity of the heart 
The heart is a four chambered muscle pump that functions to distribute blood to all the organs in 
the body [15]. It is comprised composed of left and right atria and left and right ventricles. The 
right side of the heart pumps blood through the pulmonary circulation and the left side of the 
heart pumps blood through the systemic circulation. The contraction of the atria and then the 
ventricles proceeds in an orderly manner and it is controlled by a specialized electrical 
conduction system comprising the sinoatrial node (SAN), the atrioventricular node (AVN), left 
and right bundle branches, and the Purkinje fibers [15]. Electrical activity of the heart is initiated 
by specialized cells in the SAN which is located in the upper part of the wall of the right atrium. 
SAN cells have the ability to spontaneously generate action potentials (APs) [16]. 
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Action potentials (APs) generated by SAN cells are rapidly conducted across the atria and then, 
after a brief delay in the AVN, are conducted rapidly across the ventricles. APs in SAN cells, as 
in other conducting and muscle cells of the heart, are caused by changes of ion conductance in 
specialized ion channels [15]. 
6. Sinoatrial node action potential 
SAN cells are able to generate spontaneous APs and set the normal electrical rate and rhythm in 
a healthy heart [17, 18]. SAN cells have unstable resting membrane potentials (Phase phase 4). 
During Phase phase 4 of the SAN AP, hyperpolarization-activated cyclic- nucleotide (HCN) 
channels or “funny current” channels open and there is an inward current carried by Na
+
 and K
+
. 
Opening of these channels leads to a small depolarization of the SAN membrane potential. L-
type and T-type Ca
2+
 currents also contribute to Phase phase 4 of the SAN AP. When the 
membrane potential reaches threshold, an AP is generated. L-type Ca
2+
 current is largely 
responsible for Phase phase 0. Closure of L-type Ca
2+
 channels and opening of K
+
 channels, 
including the delayed rectifier channels IKr and IKs repolarize the cell giving rise to Phase phase 3 
of the AP [17, 19]. 
7. Ventricular muscle action potential 
The cardiac muscle AP includes five phases. APs generated in the SAN spreads rapidly across 
the atria and stimulate atrial muscle contraction. The P wave of the electrocardiogram represents 
depolarization of the atria. Electrical activity then travels to the AVN where there is a brief delay 
before electrical activity spreads rapidly across the ventricular myocardium. The QRS wave of 
the electrocardiogram reflects ventricular depolarization and the T wave reflects ventricular 
repolarization [17, 18]. 
Phase 0 of the AP is caused by the opening of fast voltage-gated Na
+ 
channels, and rapid 
regenerative influx of Na
+
, which depolarizes the membrane from the resting membrane potential 
(− -90 90 mV) to around +30  30 mV. The Na
+
 channels quickly inactivate and a transient 
opening of K
+
 channels produces a transient early repolarization and Phase phase 1 of the AP. 
The plateau Phase phase 2 mainly results from opening of voltage-gated L-type Ca
2+
 channels. 
The closure of L-type Ca
2+
 channels and opening of voltage-gated K
+
 channels lead to 
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repolarization and Phase phase 3 of the AP. Finally, the membrane potential returns to resting 
levels [20, 21]. 
The AVN may be thought of as the secondary pacemaker of the heart. The AVN is a sub-
endocardial structure located in the inferior-posterior right atrium, within an anatomic region 
bordered posteriorly by the coronary sinus ostium, superiorly by the tendon of Todaro and 
anteriorly by the septal tricuspid valve annulus. This anatomic region is also commonly referred 
to as “triangle of Koch”. ”. The AVN beats at a lower rate than the SAN, around 40-–60 beats per 
minute. The delay in signal transmission in the AVN is to allow the atria to finish contraction 
before the ventricular chambers contract. After passage through the AVN, the wave of 
depolarization spreads rapidly to the Bundle of His, left and right bundle branches of the 
Purkinje system, and across the ventricular myocardium (QRS wave) [17, 19, 21]. 
8. Excitation-contraction coupling 
The process of excitation-contraction coupling (ECC) connects the electrical with mechanical 
activity of heart muscle (Figure Fig. 3). The generation of an electrical AP leads to opening of L-
type Ca
2+
 channels during Phase phase 2 of the AP followed by a small influx of Ca
2+
. This small 
influx of Ca
2+
 binds to ryanodine receptors (RYR) in the sarcoplasmic reticulum (SR) and 
triggers a large release of Ca
2+
 from the SR. This process is referred to as Ca
2+
-induced Ca
2+
 
release (CICR) and leads to a rise in cytoplasmic Ca
2+
 concentration, normally referred to as the 
Ca
2+
 transient. The elevated cytosolic Ca
2+
 binds to Troponin-C (TnC) which causes 
Tropomyosin (Tm) to reveal the active binding site of the myosin myofilaments causing a shift 
and binding of myosin to actin proteins causing muscle contraction. After completing the cycle, 
the muscle relaxes and the Ca
2+
 is released from the myofilaments. Ca
2+
 that was released from 
the SR is returned to the SR via the Ca
2+
-ATPase (SERCA) pump. Ca
2+
 that entered the cell via 
L-type Ca
2+
 channels is extruded from the cell primarily via the Na
+
/ Ca
2+
 exchanger (NCX), but 
to a lesser extent via the cell membrane Ca
2+
 ATPase (Figure Fig. 3) [18, 19, 22–26]. 
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Figure Fig. 3: Diagram showing the process of excitation-contraction coupling in the heart 
(Adapted adapted from [23]). 
9. Voltage-gated ion channels of the heart 
Since the propagation of APs depends on voltage-gated ion channels, it is helpful to discuss these 
channels in more detail, as their dysfunction can results in CVDs. Voltage-gated ion channels are 
transmembrane proteins that control physiological processes such as cardiac muscle cell 
contraction and relaxation (Figure Fig. 4). Voltage-gated Na
+
 channels and voltage-gated Ca
2+
 
channels are present in the cell membranes of most excitable cells [20, 21, 27, 28]. 
Voltage-gated Na
+
 channels are composed of one α subunit and one or two β subunits. The α 
subunit consists of four homologous domain regions (I-–IV) of six transmembrane spanning 
segments (S1-–S6) and a pore pore-forming loop. It is hypothesized that the S4 segment is the 
voltage sensor and channel gating modulator. The pore region, which allows the passage of Na
+ 
ions, also has a fatty acyl chain that allows the passage of hydrophobic small blocking drugs. The 
pore-region of the Na
+
 channel α submit, an “Asp-Glu-Lys-Ala” (DEKA) motif, determines Na
+
 
selectivity [20, 21, 27, 28]. 
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Voltage-gated Ca
2+
 channels are proteins that allow the passage of Ca
2+ 
into cells. They are 
hetero-oligomeric complexes of different subunits of α, β, γ, and δ that assemble into 5 units, the 
pore-forming α subunit (α1) and at least two accessory subunits α2δ and β, ; hence, the term 
“hetero-oligomeric”. So far, 10 cloned α-subunits have been identified and they make up five 
different families including: (1) L-type Ca
2+
 dihydropyridine-sensitive (high voltage long or slow 
activating), (2) T-type Ca
2+ 
(low voltage or transient), (3) N-type Ca
2+
 (neuron pre-synapse), (4) 
P-type Ca
2+
 (Purkinje cells), and (5) R-type Ca
2+
 (resistant to peptide toxins). The T-type and L-
type Ca
2+ 
channels variously contribute to pacemaker cell APs. Each α-subunit is composed of 
four homologous regions (I-–IV) of six transmembrane domains (S1-–S6) where the S4 is also 
responsible for the gating function. The α2δ and β subunits enhance expression and modulate the 
voltage dependence and gating kinetics of the α1 subunit [20, 23, 24]. 
Potassium (K
+
) channels can be classified into three main groups depending on their pore-
forming channel structures. The first group of voltage-dependent K
+
 currents (Kv) derived from 
six families of channel proteins are based upon Drosophila melanogaster nomenclature. K
+
 
currents included in this group consist of the transient outward K
+
 channels, Ca
2+
 activated K
+
 
channels, and KCNQ channels, all of which form tetrameric structures comprised composed of 
six transmembrane segments (S1-–S6) subunits and cytoplasmic N- and C-termini. The S1-–S4 
segments move in response to voltage changes, functioning as the voltage sensor for the channel. 
The second group of K
+
 channels consists of two transmembrane segments (S1–S2), conducting 
three inward K
+
 currents: the inward-rectifying K
+
 (Kir) channels, ATP-sensitive K
+
 (KATP) 
channels, and G protein-coupled inwardly-rectifying K
+
 (GIRK) channels [29]. The S1 and S2 
segments are connected by a pore-forming P-loop. The third group of K
+
 channels is the most 
abundant, with more than 50 members all of which have a two-pore (P1 and P2) structure with 
four transmembrane segments (S1–S4). The glycine-tyrosine-glycine (GYG) motif in the pore 
region is the critical sequence responsible for K
+
 selectivity. A gene called “KCNH2” encodes 
the Kv11.1 channel, also known as the human Ether-à-go-go related gene (hERG), which carries 
the inward delayed rectifier K
+
 current (IKr), a key component of repolarization during the 
cardiac AP. Blockade of IKr delays cardiac repolarization, thereby prolonging AP duration (APD) 
and the QT interval of the electrocardiogram, and potentially increases the risk for the 
development of the cardiac arrhythmia such as: Torsades de Pointes (TdP). The molecular 
structures of the different cation channels are shown in Figure Fig. 4 [23, 25, 26, 30]. 
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Figure Fig. 4: Diagram showing the structure of voltage-gated Na
+
, Ca
2+
, and K
+
 channels 
(Adapted adapted from [31]). 
10. Development of diabetic cardiomyopathy 
Since more than 80% of obese patients usually die from DCM, then it is important to understand 
the pathophysiology of this disease and the associated risk factors which include dyslipidemia, 
hypertension, diet, obesity, smoking, reduced physical exercise, and genetics [32, 33]. It is well 
known that DM can induce both short-term as well as long-term complications due to damage of 
the blood vessels in different organs of the body. Some of these complications include 
macrovascular diseases such as hypertension, hyperlipidemia, heart attacks, coronary artery 
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disease, strokes, cerebral vascular disease, and peripheral vascular disease. Other complications 
include microvascular diseases such as retinopathy, nephropathy, and neuropathy. Macrovascular 
complications, and to a lesser extent microvascular as in nephropathy, can lead to DCM [34–36]. 
DCM is a major adverse complication of T2DM which is characterized by defects in both 
diastolic and systolic function. In T2DM, factors contributing to DCM include defective 
regulation of cellular Ca
2+
 homeostasis due to dysregulation of cellular Ca
2+ 
transporting 
proteins. First, there is a significant impairment in sarcolemmal Na
+
/Ca
2+
 exchanger activity, 
which limits the ability of the diabetic heart to extrude Ca
2+ 
leading to an elevation in diastolic 
[Ca
2+
]i. Second, there is a decrease in Na
+
/K
+
 ATPase activity, which is known to increase 
[Ca
2+
]i secondary to a rise in [Na
+
]i. Third, Ca
2+
 influx via the Ca
2+
 channel may be increased 
[32]. Fourth, the activity of SERCA is reduced and fifth, the RYR functions in an asynchronous 
manner which may also lead to elevated diastolic Ca
2+
 [29, 31]. In addition, dysfunction of both 
vascular endothelial cells and cardiomyocytes can also contribute to the pathogenesis of DCM 
due hyperglycemia leading to oxidative stress, elevation in methylglyoxal, fibrosis, hypertrophy, 
and remodeling of the heart [33, 37]. Since DCM is a major hallmark of DM including both 
T1DM and T2DM and since obesity also plays a role in the development of T2DM, it is relevant 
to discuss the mechanism(s) of obesity-induced DM, as in the ZDF rat. 
11. Zucker diabetic fatty rat as an experimental model of type 2 
diabetes mellitus and obesity 
Strain identification 
ZDF rats were derived from the Zucker fatty (ZF) rat and is are widely used for T2DM research. 
The ZF rat inherits obesity as an autosomal Mendelian recessive trait. The ZF rat has a missense 
mutation (fatty, fa) in the leptin receptor gene (Lepr) which develops obesity without DM. A 
missense mutation (an A to C conversion at nucleotide position 806) was found in the 
extracellular domain of all the isoforms in ZF (fa/fa) rats, which resulted in an amino acid 
change from glycine (Gln) to proline (Pro) at + 269. These Ob-R isoform messenger ribonucleic 
acids (mRNAs) were present in the brain from ZF (fa/fa) rats at similar amounts to those in their 
lean littermates [38]. These rats are obese, hyper-insulinemic, and hyperphagic, ; however, blood 
glucose remains at normal levels. ZF rats usually eat more than normal rats, so their response to 
the alterations in food and cold is more like that of normal rats than rats with hypothalamic 
13 
 
obesity. The hypertriglyceridemia which characterizes these animals is normally due to the 
increased hepatic production of VLDL. Adipocytes are increased both in number and in size, and 
usually, the subcutaneous fat depot has the highest number of fat cells. Lipogenesis from glucose 
is rapid in young animals but declines with age. Enzymatic patterns of glycolysis and 
gluconeogenesis appear to reflect the altered internal environment rather than specific defects. 
Endocrine changes in the fatty rat include reduced levels of glucagon, hyper-insulinemia, 
hypothyroidism, then during their first introduction they had an impaired reproductive function 
[39]. 
From a ZF rat colony [13], a new strain fa/fa homozygous male rats with reproductive ability 
were found by mating fa/fa males and fa/+ heterozygous females. This new strain of fa/fa male 
rats exhibited DM-selective breeding and relatively high blood glucose levels at 10 10 weeks of 
age resulted in the establishment of a diabetic strain that were designated: ZDF -Lepr 𝑓𝑎. These 
homozygous fa/fa male rats developed DM as early as 10 10 weeks of age, reaching 100% 
incidence by 21 21 weeks of age, while none of the fa/+ male rats developed DM. The 
phenotypic characteristics of this diabetic strain are distinct from those of normo-glycemic ZF 
rats. The ZDF rat strain with a high reproductive efficiency serves as a useful animal model of 
T2DM [13]. 
Various studies have demonstrated progressive functional and structural changes in both the 
heart and kidney, starting as early as 16 16 weeks, without evidence that one pathology precedes 
or causes the other in the ZDF rat [40]. 
12. Metabolic changes in the Zucker diabetic fatty rat heart 
Several studies have reported that marked metabolic changes in the ZDF rat heart compared to 
healthy controls were elevated [40, 41]. There is an increase in ROS production and lipid 
peroxidation, an increase in cytochrome (CYP4502E1) activity accompanied by increased 
protein expression, oxidative protein carbonylation, and increased expression of other oxidative 
stress marker proteins including HO-1 and iNO. Similarly, glutathione (GSH) concentration and 
activities of GSH-dependent enzymes, glutathione S-transferase, and GSH reductase are also 
significantly increased in ZDF rat heart tissues suggesting a compensatory defense mechanism 
[41]. The activities of mitochondrial respiratory enzymes complex I and complex IV are reduced 
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in the ventricle of ZDF compared to Zucker lean (ZL) control rats. Other studies have reported 
decreased expression of IκB-α and phosphorylated-JNK in diabetic heart tissue. It was also 
reported that mitochondrial dysfunction and increased oxidative stress in ZDF rats might be 
associated, at least in part, with altered NF-κB/JNK JNK-dependent redox cell signaling [41]. 
In another study, contractility of ventricular myocytes was well maintained regardless of altered 
mechanisms of Ca
2+
 transport and a changing pattern of mRNA in aged ZDF rat heart. 
Expression of genes encoding cardiac muscle proteins, membrane Ca
2+
 channels, and cell 
membrane ion transport and intracellular Ca
2+
 transport proteins were variously altered. Myh6, 
Tnnt2, Cacna2d3, Slc9a1, and Atp2a2 were downregulated while Myl2, Cacna1g, Cacna1h, and 
Atp2a1 were upregulated in ZDF ventricle compared to ZL controls. Well-preserved ventricular 
myocyte shortening was linked to an altered pattern of genes encoding different Ca
2+
 signaling 
and cardiac muscle proteins in aged ZDF rats [42, 43]. 
In another study, increased mechanical stiffness, altered extracellular matrix, and a pro-fibrotic 
gene expression profile were observed in the aorta of the insulin insulin-resistant ZF fa/fa rat. 
Mechanical studies in ZF fa/fa aortas demonstrated increased vascular stiffness in longitudinal 
and circumferential directions compared with ZL controls. The results also demonstrated unequal 
elevations in developed strain favoring the longitudinal direction, which resulted in a loss of 
anisotropy. Increased expression of fibronectin and collagen IV3 have been reported in the ZF 
fa/fa aorta. Similarly, mRNA expression of transforming growth factor and numerous Smad 
proteins were increased in vessels from insulin resistant animals implicating a role for 
hyperinsulinemia in vascular stiffness. These data provide  mechanical, structural, and molecular 
evidence for arteriosclerosis in the ZF fa/fa rat, all of which are hallmarks of DCM [44]. 
Previous studies have shown that T2DM that is linked to CVD progression in female and male 
ZDF rats is mechanistically and structurally different [45]. Male rats display cardiac fibrosis and 
significant inhibition of intra-cardiac anti-fibrotic and anti-inflammatory cytokines. On the other 
hand, female rat hearts are protected from loss of anti-fibrotic cytokines and do not develop 
fibrosis. However, they still exhibit cardiac and cardiomyocyte hypertrophy, as shown by 
increased phosphorylation of Ser2448 residue of mTOR. Reduced capillary density was common 
in both male and female rats. It is possible that cardiac hypertrophy, capillary rarefaction, and a 
female-specific loss of cardio-reparative angiotensin II receptor 2 (Agtr2) in the setting of a very 
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high expression of pro-hypertrophic miR-208a (a biomarker that promotes cardiac hypertrophy) 
could have contributed to increased myocardial structural damage in the form of cardiomyocyte 
loss and scarring. This study highlights the need for new cardiac assessments such as non-
invasive imaging in diabetic female patients to detect myocardial deformation, cardiac 
hypertrophy and capillary density [45]. 
13. Involvement of micro-RNA in diabetic cardiomyopathy 
Micro-RNAs may provide valuable insight into disease progression. Micro-RNAs are small non-
coding RNAs around 22 nucleotides in length that regulate expression of target genes through 
sequence-specific hybridization to the 3′ untranslated region of messenger RNAs and either 
block translation or direct degradation of their target messenger RNA [46]. In a study by Delic et 
al. [47], the onset and progression of DM was followed in ZDF rats from 6 until 17 17 weeks of 
age. Using TaqMan miRNA arrays, circulating micro-RNAs were measured from plasma 
samples at four time points: pre-diabetes (6 6 weeks), hyperinsulinemia (8 8 weeks), β cell 
failure (11 11 weeks), and late-stage diabetes (17 17 weeks). Analysis of the data revealed 
variations of circulating micro-RNAs over time. Several micro-RNAs were found to be increased 
over the course of the disease progression including miR-122, miR-133, miR-210, and miR-375. 
The most significantly decreased micro-RNAs were miR-140, miR-151-3p, miR-185, miR-203, 
miR-434-3p, and miR-450a. Some of the micro-RNAs have also been identified in T2DM 
patients. Hence, micro-RNAs potentially provide useful biomarkers for T2DM progression [46]. 
The effects of aerobic exercise training (AET) on miRNA-16 and its target gene vascular 
endothelial growth factors (VEGF) have also been investigated in ZF rats. AET induced cardiac 
angiogenesis and reversed the microvascular rarefaction in the ZF rats. Revascularization is 
associated with a decrease in miRNA-16 expression and an increased VEGF protein expression, 
suggesting a mechanism for potential therapeutic application in vascular diseases [48].  
14. Autonomic innervation in the Zucker rat 
Increased very- low-density lipoprotein−triglyceride (VLDL–TG) secretion by the liver in ZF 
(fa/fa) rat model for dyslipidemia is due to relative hyperactivity of sympathetic and/or hypo-
activity of parasympathetic hepatic innervation [49]. Experiments have been performed to 
investigate the involvement of the autonomic nervous system by surgical denervation of either 
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the sympathetic or parasympathetic hepatic nerves in ZF rats. The results demonstrate that 
cutting the sympathetic hepatic nerve lowers VLDL–TG secretion in obese rats subsequently 
lowering plasma TG concentrations after 6 6 weeks. On the other hand, a parasympathetic 
denervation resulted in an increased plasma total cholesterol concentration. The effects of either 
sympathetic or parasympathetic denervation of the liver were independent of changes in humoral 
factors or changes in body weight or food intake. In summary, there is much evidence to indicate 
that sympathetic denervation improves the lipid profile in ZF rats, while parasympathetic 
denervation increases total cholesterol levels [49].   
15. Mechanisms underlying diabetic cardiomyopathy in the Zucker 
diabetic fatty rat 
Marked systolic dysfunction in T1DM is linked with severe nitro-oxidative stress, apoptosis, and 
fibrosis. These pathological features are either less noticeable or absent, while cardiomyocyte 
hypertrophy was comparable in T2DM, which is linked to unaltered systolic function and 
increased diastolic stiffness. mRNA-expression of hypertrophy markers c-fos, c-jun, and β-
MHC, in addition to pro-apoptotic caspase-12, is elevated in T1DM, while it persisted or only 
slightly increased in T2DM. Expression of the profibrotic TGF-β1 is upregulated in T1DM and 
showed a decrease in T2DM [50]. 
In ventricular myocytes from ZDF rats, alterations in the time course of contraction and Ca
2+
 
transients could be due to changing expression of genes encoding myosin heavy chain and L-
type Ca
2+
 channel proteins [42]. At the early stages of DM, changing the pattern of genes 
encoding cardiac muscle regulatory proteins, may provide biomarkers signaling the onset of 
cardiac muscle pathophysiology and opportunities for corrective interventions in T2DM heart 
[42]. 
At 11 weeks of age, experiments in the isolated perfused ZDF heart demonstrated preserved 
endothelium-dependent dilatation of the coronary microvasculature regardless of the increased 
oxidative stress, depressed cardiac mechanical function and coronary flow [51].  Another study 
investigated whether skeletal muscle arteriolar vasoconstrictor dysfunction comes first or occurs 
simultaneously with the onset of diabetes and hypertension. Male ZDF rats, aged 7, 13, and 20 
20 months, were used to represent pre-diabetic, short-term and long-term diabetic states, 
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respectively [52]. Vasoconstrictor responses, passive mechanical properties of isolated skeletal 
muscle arterioles as well as conscious mean arterial pressure (MAP), fasting plasma insulin and 
glucose were measured. The study concluded that the changes in vascular function resulting from 
T2DM at the selected time points are distinct in the progression of this disease. Also, in skeletal 
muscle arteriole, increased vasoconstrictor responses to norepinephrine (NE) and endothelin-1 
(ET-1) in pre-diabetes are arbitrated by a decrement in the counter-influence of the NOS (nitric 
oxide synthase) signaling mechanism. The results of this study [52] suggested that an early 
increase in adrenergic- and ET-1-mediated vasoconstriction contribute to the synchronized 
emergence of hypertension and diabetes. Additionally, it also suggested that interventions 
intended to increase NO (nitric oxide) bioavailability during the pre-diabetic state may help 
combat the hypertension associated with the onset of T2DM [52]. 
Development of T2DM in ZDF rats and the impact of ageing on cardiomyocyte function have 
been  investigated by Fulop et al.  [53]. Their studies demonstrated that an increase in O-linked 
N-acetylglucosamine (O-GlcNAc) on specific proteins may contribute to impaired 
cardiomyocyte function in diabetes and the  elevated level of O-GlcNAc on different proteins 
appears to be differentially regulated by age and diabetes [53]. 
Recently, an emerging mediator of cardiac contractility was found to be the myocardial isoform 
of Ca
2+
/calmodulin-dependent protein kinase II-delta (CaMKIIδ). It is a multifunctional 
serine/threonine protein kinase that regulates proteins associated with cardiac Ca
2+
 flux, 
including RYR and L-type Ca
2+
 channels as well as proteins integral to sarcomere cross bridge 
cycling and structure. CaMKIIδ plays an important role in cardiac contraction and relaxation. 
Persistent activation of CaMKIIδ is linked to some cardiac pathologies, including maladaptive 
hypertrophy, apoptosis and arrhythmias. CaMKIIδ activity was found to be enhanced during 
hyperglycemia and may alter intracellular Ca
2+
 handling in cardiomyocytes, ultimately leading to 
reduced cardiac performance. Daniels et al. [51] investigated the effects of CaMKIIδ on cardiac 
contractility in ZDF rats. Their results showed that CaMKIIδ has a crucial role in modulating 
performance of the diabetic heart, suggesting a potential therapeutic role for Ca
2+
/calmodulin-
dependent kinase II (CaMKII) inhibitors in improving myocardial function during T2DM [54]. 
Cardiac NE overflow was also investigated in ZDF rats. The results indicate that cardiac NE 
overflow is inhibited in failing hearts from ZDF rats which may result from the inhibition of 
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functional alterations of presynaptic alpha 2-adrenoceptors and may contribute to cardiac 
autonomic neuropathy [55]. 
The relationship between cardiomyocyte rich perivascular tissue and coronary arteries has been 
investigated in ZDF rats. Specifically, the vasoactive effects of perivascular tissue in arteries 
from the ZDF rat was compared with other animal models of T2DM. Vasocontractile and 
vasorelaxant functions of coronary septal arteries with and without perivascular tissue were 
investigated using wire myography. The experiments confirmed the anti-contractile influences of 
perivascular tissue are weakened in coronary arteries from ZDF rats, but unaffected in arteries 
from STZ treated rats. Endothelial dysfunction was reported in coronary septal arteries, with and 
without perivascular tissue, from ZDF rats but not STZ treated rats. Different signaling between 
cardiomyocyte rich perivascular tissue and coronary arteries can contribute to cardiovascular 
complications in T2DM [56].   
In isolated hearts from ZDF rats, the impact of altered substrate utilization on cardiac function 
was investigated to determine whether changes in cardiac metabolism in T2DM are associated 
with contractile dysfunction or impaired response to ischemia. Hearts from ZDF and ZL control 
rats were isolated and perfused with glucose, lactate, pyruvate, and palmitate. The experiments 
showed that a shift from carbohydrates to fatty acids for oxidative energy production did not 
increase myocardial oxygen consumption and was not linked with impaired response to ischemia 
and reperfusion [57]. 
The storage of fat within heart muscle has been linked with decreased force production, which 
has consequences for the heart to pump blood effectively and lipid accumulation within cardiac 
muscle has been associated with heart failure. Fats from the blood can be moved into heart 
muscle cells, where they can either be stored or used for generating energy within the 
mitochondria. Experiments in the ZDF rat demonstrated that more fat accumulates within the 
heart as a result of their increased transport across the membranes of heart cells, not due to 
reductions in mitochondrial number or function, indicating that lipids accumulate in the heart 
despite normal mitochondrial content, long-chain fatty acid oxidation and morphology [58]. 
Instead, increased sarcolemma long-chain fatty acid (LCFA) transport proteins and rates of 
LCFA transport result in a greater number of lipid droplets within cardiac muscle [58]. 
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16. Mechanisms underlying electro-mechanical dysfunction in the 
Zucker diabetic fatty rat heart 
Early signs of diabetic autonomic neuropathy in the electrocardiogram include elevated R wave 
amplitudes, widening of QTc intervals and decreased heart rate variability (HRV). The severity 
of neuropathy has a direct relationship with mortality risk. AET is a common recommendation 
for the postponement and possible reversal of cardiac dysfunction. Limited research is currently 
available on the effects of AET on the electrocardiogram in the ZDF rat. One study demonstrated 
alterations in R wave amplitudes, HRV, QT and QTc intervals in ZDF rats. AET had beneficial 
effects and was able to correct R wave amplitude changes as well as electrocardiogram correlates 
of left ventricular mass [59]. 
Experiments have been performed in SAN from the right atria of male Sprague-Dawley, ZF and 
ZL rats, as well as the ventricles of male Sprague-Dawley rats to investigate the direct actions of 
leptin on heart rate and ventricular repolarization. Leptin is a 16-kda adipokine released from 
adipocytes acting through its receptor. Leptin receptors and adipocytes are present in the 
myocardium. It has been proposed that leptin can modulate cardiac electrical properties via β-
adrenergic receptor activation and that it can directly modulate cardiac electrical properties such 
as heart rate and QT interval via its receptor. The results from the study showed that leptin, at 
low doses (0.1–30 30 μg/kg), decreased resting heart rate while at high doses (150–300  μg/kg), 
); it induced a biphasic effect (decrease and then increase) on heart rate. In the presence of the β-
blocker propranolol (30 30 mg/kg), high-dose leptin only reduced heart rate and occasionally 
caused ventricular tachycardia and sinus pauses. This leptin-induced inhibition of resting heart 
rate was fully reversed by leptin antagonist. Leptin also increased the QTc interval, however, 
leptin antagonist did not reverse these effects. Furthermore, in isolated ventricular myocytes, 
leptin (0.03–0.3 3 μg/ml) reversibly increased APD. In summary, leptin can directly decrease 
heart rate and increase QT interval via its receptor independent of β-adrenergic receptor 
stimulation. During inhibition of β-adrenergic receptor activity, high concentrations of leptin in 
the myocardium can cause bradycardia, prolonged QT interval, and ventricular arrhythmias. In 
general, these findings may offer a better understanding of higher incidence of prolonged QT and 
sudden cardiac death in obesity [60]. 
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The sympathetic nervous system exerts its chronotropic, inotropic and lusitropic effects on the 
heart mainly by means of β-adrenoceptors (β-ARs), of which three different β-AR subtypes (β1, 
β2 and β3) exist [61]. Impaired β-adrenoceptor (β-AR) responsiveness can have consequences 
for heart function in patients with T2DM. For this reason, specific β1 and β2-AR responsiveness 
of heart rate, contraction and relaxation in the diabetic heart were investigated. In general, 
diabetic hearts showed lower basal heart rates compared to controls. AMP-activated protein 
kinase (AMPK), a key regulator of cardiac energy metabolism [62], which was also linked to β-
AR, and specifically to β2-AR had 41% higher protein phosphorylation levels in diabetic heart 
[63–65]. In summary, β1-adrenoceptors are the main subtype regulating heart rate, contraction, 
and relaxation which in turn regulate chronotropic, inotropic, and lusitropic β-AR responses in 
the healthy heart and the T2DM heart. Moreover, the β2-AR subtype indirectly supports the β1-
AR functional response in the diabetic heart [66]. 
Mortality and morbidity following an acute myocardial infarction in patients with T2DM may be 
caused by increased sensitivity to either ischemia reperfusion (IR) injury or altered activation of 
endogenous cardioprotective pathways modified by T2DM or ischemic preconditioning (IPC). 
Results from a previous study [67] showed that IPC reduced infarct size in all groups irrespective 
of the presence of T2DM and its duration. Compared to prediabetic rats, myocardial glucose 
oxidation rates were reduced during stabilization and early reperfusion at the onset of T2DM, but 
these animals retained the ability to increase oxidation rate in late reperfusion. Nevertheless, late 
stage diabetic rats had low glucose oxidation rates throughout reperfusion and stabilization. 
Regardless of intrinsic differences in sensitivity to IR injury, the cardioprotective effect of IPC 
was conserved in pre, early, and late stage T2DM and was associated with adaptations to 
myocardial glucose oxidation capacity [67]. 
As mentioned earlier in the review, CaMKIIδ plays an important role in cardiac contraction and 
relaxation. Since it plays an important part in altering intracellular Ca
2+
 transport in 
cardiomyocytes, ultimately leading to reduced cardiac performance, it is important to consider it 
as one of the mechanisms underlying electro-mechanical dysfunction in ZDF hearts [54]. An 
example of such dysfunction is AF which is associated with high morbidity and mortality. Both 
structural and electrical remodeling contribute to AF. A role for Ca
2+/calmodulin-dependent 
protein kinase II (CaMKII) in the regulation of persistent late Na+ current has been identified. A 
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computational approach was used to test the hypothesis that increased CaMKII-activated late 
Na
+
 current in atrial myocytes alters Ca
2+ homeostasis thereby contributing to arrhythmogenic 
after-depolarizations. Dynamic CaMKII activity and regulation of multiple downstream targets 
including late Na
+
 current, L-type Ca
2+ current, phospholamban, and the SR RYR Ca
2+-release 
channel, were combined into an existing well-validated computational model of the human atrial 
action potential. Model simulations showed that constitutive CaMKII-dependent phosphorylation 
of NaV1.5 and the subsequent increase in late Na
+
 current upset intracellular atrial myocyte 
CaMKII signaling and Ca
2+
 homeostasis. Increased late Na
+
 current promotes intracellular Ca
2+ 
overload via forward mode Na+/Ca
2+ exchange activity, which increases RYR open probability 
beyond that observed for CaMKII-dependent phosphorylation of RYR alone. Increased late Na
+
 
current contributes to atrial myocyte repolarization defects (afterdepolarizations and alternans) in 
the setting of acute β-adrenergic stimulation. The model was used in an effort to help in 
identifying new mechanisms for atrial NaV1.5 regulation with direct relevance to human AF [68]. 
In T2DM, impaired endothelium-dependent relaxation is due to a loss of endothelium derived 
hyperpolarization (EDH) that is controlled by diminished ion channel function in ZDF and ZL 
rats. It is proposed that the compensatory effect of NO and EDH-associated, endothelium-
dependent relaxation is reduced in ZDF rats. Specific blockade of IKCa with TRAM-34 reduces 
NO and EDH-type relaxation in diabetic rats, indicating an elevated contribution of IKCa in 
diabetic small mesenteric artery (SMA) relaxation. This result associates with increased IKCa 
mRNA and protein expression which suggests an important role for IKCa in diabetic SMA as a 
target for innovative treatment strategies [69]. 
Decreased conduction velocity (CV), which is determined by excitability, internal electrical 
resistance and cardiac structure, is an independent risk factor for re-entry arrhythmias. The 
internal electrical resistance can be viewed as two resistors in series: first, the resistance of the 
cell cytoplasm, which is determined by the cellular composition, e.g., the number of intracellular 
organelles and non-conducting material like lipid droplets and second, the resistance at the cell-
cell junctions [70]. It was found out that the CV is reduced in ZDF rats. The CV disturbance may 
be partially explained by increased lateralization of connexin43. Moreover, lipotoxicity may play 
a role in development of conduction disturbances and arrhythmias in T2DM [71].   
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By comparing speckle-tracking echocardiography (STE)-derived parameters to the indices of left 
ventricular pressure volume (LVPV) analysis to detect cardiac dysfunction in rat models of 
T1DM (STZ) and T2DM (ZDF), it was found that in T1DM, contractility and active relaxation 
deteriorated to a greater extent compared to T2DM. In contrast, diastolic stiffness was impaired 
in T2DM. Similarly, STE revealed more severe systolic dysfunction in T1DM. Among diastolic 
STE parameters, peak strain rate values in isovolumic relaxation (SrIVR) was were more 
decreased in T1DM, ; however, peak strain rate values in early diastole (SrE) was were more 
reduced in T2DM. In T1DM, peak strain rate values in systole (SrS) correlated with contractility, 
SrIVR with active relaxation, while in T2DM SrE was related to cardiac stiffness, cardiomyocyte 
diameter, and fibrosis. In summary, strain and strain rate parameters provide valuable 
physiological measures of dynamic changes in contractility, active relaxation, and LV stiffness in 
animal models of T1DM and T2DM. STE corresponds to PV analysis and also correlates with 
markers of histological myocardial remodeling [72]. Figure 5 shows the possible mechanism(s) 
of electro-mechanical dysfunction in T2DM heart. 
 
Figure Fig. 5: Possible mechanism(s) of electro-mechanical dysfunction in T2DM heart 
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17. Conclusion 
Figure 6 summarizes the time course of pathological changes that are taking place in the ZDF rat 
heart and that may lead to sudden cardiac death. This review provides evidence that the obese-
induced ZDF rat model is a useful experimental model to study the pathophysiology induced by 
T2DM and obesity in different organs of the body, especially the heart. In terms of mechanical 
function of ZDF heart, the change in time course of contraction and Ca
2+
 transients may be due 
to changing expression of genes encoding L-type Ca
2+
 channel proteins [42]. The cardiac 
contractility and the myocardial isoform of Ca
2+
/calmodulin-dependent protein kinase II 
(CaMKIIδ) were found to be important in cardiac performance [54]. However, more studies are 
required to clarify the cellular, subcellular, and molecular basis of electro-mechanical 
dysfunction in the ZDF rat heart since they can lead to bradyarrhythmias and sudden cardiac 
death. 
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Figure Fig. 6:  Flow diagram summarizing the pathological changes that are taking place in the 
ZDF rat heart, subsequently leading to sudden cardiac death\ 
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